AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/117
CLINICAL-EXPERIENCE WITH ABCIXIMAB DURING CORONARY REVASCULARIZATION - AN OVERVIEW
Authors: GUETTA V LINCOFF AM
Citation: V. Guetta et Am. Lincoff, CLINICAL-EXPERIENCE WITH ABCIXIMAB DURING CORONARY REVASCULARIZATION - AN OVERVIEW, Biodrugs, 10(1), 1998, pp. 27-39
REDUCTION IN COMPLICATIONS OF ANGIOPLASTY WITH ABCIXIMAB OCCURS LARGELY INDEPENDENTLY OF BASE-LINE LESION MORPHOLOGY
Authors: ELLIS SG LINCOFF AM MILLER D TCHENG JE KLEIMAN NS KEREIAKES D CALIFF R TOPOL EJ
Citation: Sg. Ellis et al., REDUCTION IN COMPLICATIONS OF ANGIOPLASTY WITH ABCIXIMAB OCCURS LARGELY INDEPENDENTLY OF BASE-LINE LESION MORPHOLOGY, Journal of the American College of Cardiology, 32(6), 1998, pp. 1619-1623
THE DURATION OF PRETREATMENT WITH TICLOPIDINE PRIOR TO STENTING IS ASSOCIATED WITH THE RISK OF PROCEDURE-RELATED NON-Q-WAVE MYOCARDIAL INFARCTIONS
Authors: STEINHUBL SR LAUER MS MUKHERJEE DP MOLITERNO DJ LINCOFF AM ELLIS SG TOPOL EJ
Citation: Sr. Steinhubl et al., THE DURATION OF PRETREATMENT WITH TICLOPIDINE PRIOR TO STENTING IS ASSOCIATED WITH THE RISK OF PROCEDURE-RELATED NON-Q-WAVE MYOCARDIAL INFARCTIONS, Journal of the American College of Cardiology, 32(5), 1998, pp. 1366-1370
MODIFIABLE RISK-FACTORS FOR VASCULAR ACCESS SITE COMPLICATIONS IN THEIMPACT-II TRIAL OF ANGIOPLASTY WITH VERSUS WITHOUT EPTIFIBATIDE
Authors: MANDAK JS BLANKENSHIP JC GARDNER LH BERKOWITZ SD AGUIRRE FV SIGMON KN TIMMIS GC GILCHRIST IC MCIVOR M RESAR J WEINER BH GEORGE BS TALLEY JD LINCOFF AM TCHENG JE CALIFF RM TOPOL EJ
Citation: Js. Mandak et al., MODIFIABLE RISK-FACTORS FOR VASCULAR ACCESS SITE COMPLICATIONS IN THEIMPACT-II TRIAL OF ANGIOPLASTY WITH VERSUS WITHOUT EPTIFIBATIDE, Journal of the American College of Cardiology, 31(7), 1998, pp. 1518-1524
COMPLEMENTARITY OF STENTING AND ABCIXIMAB FOR PERCUTANEOUS CORONARY INTERVENTION
Authors: KEREIAKES DJ LINCOFF AM SIMOONS ML DEBOER MJ TCHENG JE VAHANIAN A ANDERSON KM WEISMAN HF CALIFF RA TOPOL EJ
Citation: Dj. Kereiakes et al., COMPLEMENTARITY OF STENTING AND ABCIXIMAB FOR PERCUTANEOUS CORONARY INTERVENTION, Journal of the American College of Cardiology, 31(2), 1998, pp. 54-54
ABCIXIMAB ASSOCIATED THROMBOCYTOPENIA - EVIDENCE FOR A COMPLEX INTERACTION WITH HEPARIN
Authors: KEREIAKES DJ BERKOWITZ SD ANDERSON K SIMOONS M VAHANIAN A LINCOFF AM TCHENG JE WEISMAN H CALIFF RM TOPOL EJ
Citation: Dj. Kereiakes et al., ABCIXIMAB ASSOCIATED THROMBOCYTOPENIA - EVIDENCE FOR A COMPLEX INTERACTION WITH HEPARIN, Journal of the American College of Cardiology, 31(2), 1998, pp. 55-55
PRIOR ASPIRIN USE POTENTIATES THE EFFECT OF GP IIB IIIA INHIBITION INPATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES/
Authors: ALEXANDER JH HARRINGTON RA GUERCI A WEATHERLEY BD KARSCH KR CALIFF RM TOPOL EJ LINCOFF AM ARMSTRONG PW
Citation: Jh. Alexander et al., PRIOR ASPIRIN USE POTENTIATES THE EFFECT OF GP IIB IIIA INHIBITION INPATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES/, Journal of the American College of Cardiology, 31(2), 1998, pp. 93-93
CLINICAL EFFICACY OF INTEGRILIN IN UNSTABLE ANGINA IS ACCOMPANIED BY A MODEST INCREASE IN HEMORRHAGIC RISK - THE PURSUIT TRIAL
Authors: LINCOFF AM HARRINGTON RA CALIFF RM BERDAN LG KITT MM WEATHERLY BD KLEIMAN NS TOPOL EJ
Citation: Am. Lincoff et al., CLINICAL EFFICACY OF INTEGRILIN IN UNSTABLE ANGINA IS ACCOMPANIED BY A MODEST INCREASE IN HEMORRHAGIC RISK - THE PURSUIT TRIAL, Journal of the American College of Cardiology, 31(2), 1998, pp. 185-185
REGIONAL VARIATION IN OUTCOMES AS DETERMINED BY INVESTIGATORS AND CLINICAL EVENTS COMMITTEE IN AN INTERNATIONAL TRIAL OF EPTIFIBATIDE IN NON-ST SEGMENT ELEVATION ACUTE CORONARY SYNDROMES
Authors: DECKERS JW HARRINGTON RA LINCOFF AM TOPOL EJ CALIFF RM BERDAN LG WEATHERLY BD WILCOX RG ARMSTRONG PW KITT MM SIMOONS ML
Citation: Jw. Deckers et al., REGIONAL VARIATION IN OUTCOMES AS DETERMINED BY INVESTIGATORS AND CLINICAL EVENTS COMMITTEE IN AN INTERNATIONAL TRIAL OF EPTIFIBATIDE IN NON-ST SEGMENT ELEVATION ACUTE CORONARY SYNDROMES, Journal of the American College of Cardiology, 31(2), 1998, pp. 309-309
PARTICULAR BENEFIT OF PLATELET GPIIB IIIA BLOCKADE AND FULL HEPARIN IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE UNDERGOING PTCA/
Authors: MILLER JM GODFREY N BALOG C LINCOFF AM TOPOL EJ
Citation: Jm. Miller et al., PARTICULAR BENEFIT OF PLATELET GPIIB IIIA BLOCKADE AND FULL HEPARIN IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE UNDERGOING PTCA/, Journal of the American College of Cardiology, 31(2), 1998, pp. 455-455
CORONARY STENTING AND USE OF ABCIXIMAB - REPLY
Authors: TOPOL EJ LINCOFF AM SAPP S
Citation: Ej. Topol et al., CORONARY STENTING AND USE OF ABCIXIMAB - REPLY, Lancet, 352(9136), 1998, pp. 1311-1312
RANDOMIZED PLACEBO-CONTROLLED AND BALLOON-ANGIOPLASTY-CONTROLLED TRIAL TO ASSESS SAFETY OF CORONARY STENTING WITH USE OF PLATELET GLYCOPROTEIN-IIB IIIA BLOCKADE/
Authors: TOPOL EJ LINCOFF AM CALIFF RM TCHENG JE KLEIMAN NS ADELMAN AG BURTON JR TALLEY JD IVANHOE RJ DUCAS C CHEUNG PK SCHICK U BADARD D KRAMER J LEARY J SNYDER H WILSON R DEAREN M CARAMORI P WEBBER S TAYLOR J FERRANDO T COHEN E BALLEZA L ROUSE C HOGG N KELLY T ALSTON S WEBB J BULLER E RICCI DR MOCKMAN S TANGUAY JF POITRAS AM TIMIS G DAVEY D COLEMAN P HERROLDRUNGE P ONEILL BJ FOSHEY K FITZGERALD N ALMOND D KOSTUK W WHITE J OSKALNS R GOTTLIEB R KOREN P PALAZZO D AZRIN M BARRY MB BLANKENSHIP J DEMKO SL KRAFT P DVORAK L BROWN R COLCLOUGH M STEVENS K SAREMBOCK I SNYDER L SAYRE S BROWNE K ROY M REEN B SHORT R THOMPSON M CHIODO V HOFFMAN D BASS TA ZENNI M ROHMAN G MARQUIS JF LABINAZ M JELLEY J FRENCH W GOLDBERG S WANG S GRADMAN A BOLTEY L COLLINS J WORLEY S HOLLYWOOD L FREY L YAKUBOV S GILLILAND C RODRIGUEZ A POTTER K TAYLOR M AJI J CLEARY E TANNENBAUM M HARTZ A RUND M SMIGLEY R LOPEZ J KUNNY P HOCHMAN J SLATER J TERMEY D BATES E FOXBRUENGER P GONZALEZ M JOPPERRI L RUNYON JP HIGBY N KRUCOFT M BOOTH T AGUIRRE F BACH R MECHEM C AZRIN M MURPHY D CUMMINS FE NONWEILER J SANZ M COLE C WESTON MW ANDERSON HV WEIGELT L LARKIN T JACKSON BJ ROSENBERG MJ TULLY S HARTMAN C LUNOW S LUCORE C MISHKEL G MCSHANE K MUHLESTEIN B JERMAN J SANDER G STEVENS A CHISHOLM R DELCORE M STENGEL L CANNATA R CASTLE V DELUCA S BALOG C KNUTH T MCCOLLOUGH T GODFREY N MELTON J MILLER D PULLIAM M SAPP S SIGMON KN TEMPLIN M MONTAGUE E CARLSON J HEIL L ZOVKIC V MALONE K RODKEY S HAAS G HARRINGTON R KAPADIS S CAMPBELL L MUKHERJEE D DEEDY M AUGOSTINI R ALEXANDER J WHELLAN D BAJZER C RABBANI R CLEMONS P BAISHNAB R RANDALL R UNDERWOOD D LAUER MA LAUER MS ROE M FARHY R SCHWEIKERT R GRADY T ELLIS S MOLITERNO D DEBOWEY D IVANC T OLS L POLISZCUK R BALAZS E WITHERSPOON B ANDERSON KM BARNATHAN E CABOT CF STONER GL WEISMAN HF
Citation: Ej. Topol et al., RANDOMIZED PLACEBO-CONTROLLED AND BALLOON-ANGIOPLASTY-CONTROLLED TRIAL TO ASSESS SAFETY OF CORONARY STENTING WITH USE OF PLATELET GLYCOPROTEIN-IIB IIIA BLOCKADE/, Lancet, 352(9122), 1998, pp. 87-92
DIABETES AND THE RESPONSE TO ARTERIAL INJURY
Authors: PARK SH MARSO SP FORUDI F LINCOFF AM
Citation: Sh. Park et al., DIABETES AND THE RESPONSE TO ARTERIAL INJURY, Circulation, 98(17), 1998, pp. 39-39
SAFETY OF ABCIXIMAB RETREATMENT - FINAL CLINICAL REPORT OF THE REOPROREADMINISTRATION REGISTRY (R-3)
Authors: TCHENG JE KEREIAKES DJ BRADEN GA LINCOFF AM MASCELLI MA LANGRALL MA DAMARAJU LV SCHANTZ AR BARNATHAN ES EFFRON MB
Citation: Je. Tcheng et al., SAFETY OF ABCIXIMAB RETREATMENT - FINAL CLINICAL REPORT OF THE REOPROREADMINISTRATION REGISTRY (R-3), Circulation, 98(17), 1998, pp. 82-82
MAINTENANCE OF CLINICAL BENEFIT AT 6-MONTHS IN PATIENTS TREATED WITH THE PLATELET GLYCOPROTEIN IIB IIIA INHIBITOR EPTIFIBATIDE VERSUS PLACEBO DURING AN ACUTE ISCHEMIC CORONARY EVENT/
Authors: HARRINGTON RA LINCOFF AM BERDAN LG MACAULAY C KINT PP MAHAFFEY KW KITT MM SIMOONS ML CALIFF RM
Citation: Ra. Harrington et al., MAINTENANCE OF CLINICAL BENEFIT AT 6-MONTHS IN PATIENTS TREATED WITH THE PLATELET GLYCOPROTEIN IIB IIIA INHIBITOR EPTIFIBATIDE VERSUS PLACEBO DURING AN ACUTE ISCHEMIC CORONARY EVENT/, Circulation, 98(17), 1998, pp. 1886-1886
THE ROLE OF INTEGRINS ALPHA(V)BETA(3) AND ALPHA(ILB)BETA(3) IN AN EXPERIMENTAL ARTERIAL INJURY MODEL
Authors: RABBANI R LEBRETON H KHURANA C PLOW EF MOUSA SA LINCOFF AM
Citation: R. Rabbani et al., THE ROLE OF INTEGRINS ALPHA(V)BETA(3) AND ALPHA(ILB)BETA(3) IN AN EXPERIMENTAL ARTERIAL INJURY MODEL, Circulation, 98(17), 1998, pp. 2813-2813
PERIPROCEDURAL MYOCARDIAL INFARCTIONS PREVENTED BY IIB-IIIA BLOCKADE ARE CLINICALLY AND ANGIOGRAPHICALLY MANIFEST AND LARGE - THE EPISTENT EXPERIENCE
Authors: LINCOFF AM BOOTH JE GODFREY NK KRAMER J KELLY T TOPOL EJ
Citation: Am. Lincoff et al., PERIPROCEDURAL MYOCARDIAL INFARCTIONS PREVENTED BY IIB-IIIA BLOCKADE ARE CLINICALLY AND ANGIOGRAPHICALLY MANIFEST AND LARGE - THE EPISTENT EXPERIENCE, Circulation, 98(17), 1998, pp. 4019-4019
THE EPISTENT TRIAL AT 6 MONTHS - RELATIVE AND COMBINED EFFECTS OF ABCIXIMAB AND STENTING ON REDUCTION OF ACUTE ISCHEMIC EVENTS AND LATE REVASCULARIZATION
Authors: LINCOFF AM TCHENG JE CALIFF RM CABOT CF BOOTH JE GODFREY NK TOPOL EJ
Citation: Am. Lincoff et al., THE EPISTENT TRIAL AT 6 MONTHS - RELATIVE AND COMBINED EFFECTS OF ABCIXIMAB AND STENTING ON REDUCTION OF ACUTE ISCHEMIC EVENTS AND LATE REVASCULARIZATION, Circulation, 98(17), 1998, pp. 4021-4021
DIABETICS AND NONDIABETICS ACHIEVE SIMILAR LEVELS OF PLATELET INHIBITION WITH ABCIXIMAB THERAPY DURING AND FOLLOWING PERCUTANEOUS REVASCULARIZATION
Authors: STEINHUBI SR KOTTKEMARCHANT KK ROSENTHAL M MOLITERNO DJ LINCOFF AM
Citation: Sr. Steinhubi et al., DIABETICS AND NONDIABETICS ACHIEVE SIMILAR LEVELS OF PLATELET INHIBITION WITH ABCIXIMAB THERAPY DURING AND FOLLOWING PERCUTANEOUS REVASCULARIZATION, Circulation, 98(17), 1998, pp. 4023-4023
6-MONTH ANGIOGRAPHIC OUTCOME WITH ABCIXIMAB AND STENTS - THE EPISTENTANGIOGRAPHIC SUBSTUDY
Authors: LINCOFF AM MOLITERNO DJ ELLIS SG DEBOWEY D CABOT CF BOOTH JE GODFREY NK TOPOL EJ
Citation: Am. Lincoff et al., 6-MONTH ANGIOGRAPHIC OUTCOME WITH ABCIXIMAB AND STENTS - THE EPISTENTANGIOGRAPHIC SUBSTUDY, Circulation, 98(17), 1998, pp. 4028-4028
IS BLEEDING RISK INCREASED IN PATIENTS UNDERGOING URGENT CORONARY-BYPASS SURGERY FOLLOWING ABCIXIMAB
Authors: BOOTH JE PATEL VB BALOG C MILLER DP JURAN NB LENARZ L LINCOFF AM
Citation: Je. Booth et al., IS BLEEDING RISK INCREASED IN PATIENTS UNDERGOING URGENT CORONARY-BYPASS SURGERY FOLLOWING ABCIXIMAB, Circulation, 98(17), 1998, pp. 4432-4432
ABCIXIMAB THERAPY AND UNPLANNED CORONARY STENT DEPLOYMENT - FAVORABLEEFFECTS ON STENT USE, CLINICAL OUTCOMES, AND BLEEDING COMPLICATIONS
Authors: KEREIAKES DJ LINCOFF AM MILLER DP TCHENG JE CABOT CF ANDERSON KM WEISMAN HF CALIFF RM TOPOL EJ
Citation: Dj. Kereiakes et al., ABCIXIMAB THERAPY AND UNPLANNED CORONARY STENT DEPLOYMENT - FAVORABLEEFFECTS ON STENT USE, CLINICAL OUTCOMES, AND BLEEDING COMPLICATIONS, Circulation, 97(9), 1998, pp. 857-864
DIABETES-MELLITUS, GLYCOPROTEIN IIB IIIA BLOCKADE, AND HEPARIN - EVIDENCE FOR A COMPLEX INTERACTION IN A MULTICENTER TRIAL/
Authors: KLEIMAN NS LINCOFF AM KEREIAKES DJ MILLER DP AGUIRRE FV ANDERSON KM WEISMAN HF CALIFF RM TOPOL EJ
Citation: Ns. Kleiman et al., DIABETES-MELLITUS, GLYCOPROTEIN IIB IIIA BLOCKADE, AND HEPARIN - EVIDENCE FOR A COMPLEX INTERACTION IN A MULTICENTER TRIAL/, Circulation, 97(19), 1998, pp. 1912-1920
REDUCTION IN THE NEED FOR UNPLANNED STENTING WITH THE USE OF PLATELETGLYCOPROTEIN IIB IIIA BLOCKADE IN PERCUTANEOUS CORONARY INTERVENTION/
Authors: BHATT DL LINCOFF AM KEREIAKES DJ TCHENG JE SIMOONS ML VANDERWIEKEN LR GODFREY N CALIFF RM TOPOL EJ
Citation: Dl. Bhatt et al., REDUCTION IN THE NEED FOR UNPLANNED STENTING WITH THE USE OF PLATELETGLYCOPROTEIN IIB IIIA BLOCKADE IN PERCUTANEOUS CORONARY INTERVENTION/, The American journal of cardiology, 82(9), 1998, pp. 1105
TRIALS OF PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONISTS DURING PERCUTANEOUS CORONARY REVASCULARIZATION/
Authors: LINCOFF AM
Citation: Am. Lincoff, TRIALS OF PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONISTS DURING PERCUTANEOUS CORONARY REVASCULARIZATION/, The American journal of cardiology, 82, 1998, pp. 36-42
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>